510(k) Report

510(k) · Cleared

Recalled · Class II · 2023

Grafton R II Edbm, Demineralized Bone Matrix Allograft, Resorbable Calcium Salt Bone Void Filler Devices

K082615510(k) TraditionalCleared Oct 16, 200837-day reviewClass II21 CFR 888.3045Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Osteotech, Inc. · MQV Filler, Bone Void, Calcium Compound

Cleared on Oct 16, 2008 after a 37-day review. The FDA summary names no predicate by number. 7 later devices descend from it. It has been recalled once.

Decided
Oct 16, 2008
Review
37 days
Class
Class II
Product code
MQV
Recalls
1
Predicates
0

7 later devices descend from it, 3 citing it directly.

Descendants, by year cleared 2017: 1 descendant cleared2013: 3 descendants cleared2021: 1 descendant cleared2020: 1 descendant cleared2019: 1 descendant cleared20052010201520202025
  1. This deviceK082615 Grafton R II Edbm, Demineralized Bone Matrix Allograft, Resorbable…Osteotech, Inc. · 2008
  2. Descendant · cites it directly · 5 of its ownK123691 Magnifuse Bone Graft (Cleared as Grafton II Edbm)Medtronic Sofamor Danek, Inc. · 2013
  3. Descendant · cites it directly · 4 of its ownK122513 Cleared Under Grafton II EdbmMedtronic Sofamor Danek, Inc. · 2013
  4. Descendant · cites it directly · 2 of its ownK172130 Resorbable Mesh DeviceSeaSpine Orthopedics Corporation · 2017 · Recalled
  5. Descendant · 2 generations on · 0 of its ownK203218 CaP Spheres Pellet PackZimmer Biomet Spine, Inc. · 2021
  6. Descendant · 2 generations on · 0 of its ownK200290 Resorbable Mesh Pouch (Ballast MT, OsteoBallast MT)SeaSpine Orthopedics Corporation · 2020

Showing 5 of 7 descendants. See all descendants

Descendants cleared per year

2013: 32017: 12019: 12020: 12021: 1
2013high 3 (2013) · low 0 (2014)2026

Most influential descendants

Showing 5 of 7 · See all
  • K123691Magnifuse Bone Graft (Cleared as Grafton II Edbm)Medtronic Sofamor Danek, Inc. · 2013 · cites it directly5descendants
  • K122513Cleared Under Grafton II EdbmMedtronic Sofamor Danek, Inc. · 2013 · cites it directly4descendants
  • K172130Resorbable Mesh DeviceSeaSpine Orthopedics Corporation · 2017 · cites it directly2descendants
  • K203218CaP Spheres Pellet PackZimmer Biomet Spine, Inc. · 2021 · 2 generations on0descendants
  • K200290Resorbable Mesh Pouch (Ballast MT, OsteoBallast MT)SeaSpine Orthopedics Corporation · 2020 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K082615Grafton R II Edbm, Demineralized Bone Matrix Allograft, Resorbable Calcium…Osteotech, Inc.2008—
+1K123691Magnifuse Bone Graft (Cleared as Grafton II Edbm)Medtronic Sofamor Danek, Inc.2013—
+1K122513Cleared Under Grafton II EdbmMedtronic Sofamor Danek, Inc.2013—
+1K172130Resorbable Mesh DeviceSeaSpine Orthopedics Corporation20171
+2K203218CaP Spheres Pellet PackZimmer Biomet Spine, Inc.2021—
+2K200290Resorbable Mesh Pouch (Ballast MT, OsteoBallast MT)SeaSpine Orthopedics Corporation2020—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201330
201710
201910
202010
202110
FIG. 1 — Lineage of K082615, 2008–2021Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MQV? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new MQV device

  1. #1 K232315 Catalyst Bone Void Fillerscore 25.2 · 25 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against?

The FDA summary names no predicate by number.

What descends from it? (7)

3 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K123691Magnifuse Bone Graft (Cleared as Grafton II Edbm)Medtronic Sofamor Danek, Inc.20135
K122513Cleared Under Grafton II EdbmMedtronic Sofamor Danek, Inc.20134
K172130Resorbable Mesh DeviceSeaSpine Orthopedics Corporation20172

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Jul 31, 2023Class IIZ-2524-2023Process controlThe incorrect product labeling was applied to the product indicating the wrong size of product.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K123691 (Medtronic Sofamor Danek, Inc., 2013) has gone furthest, with 5 descendants of its own.

How does its category compare?

All MQV devices

MQV Filler, Bone Void, Calcium Compound: FDA decisions, review times, recalls and adverse event reports over 20 years. 2008, this device’s year, is highlighted.

FDA decisions per year · MQV

14in 2025

2007: 352008: 322009: 232010: 172011: 162012: 92013: 122014: 202015: 182016: 82017: 172018: 232019: 132020: 152021: 82022: 92023: 212024: 282025: 142026 (partial year): 5
2007high 35 (2007) · low 8 (2016)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MQV

57in 2025

2007: 144 days median2008: 102 days median2009: 180 days median2010: 147 days median2011: 92 days median2012: 107 days median2013: 197 days median2014: 153 days median2015: 184 days median2016: 214 days median2017: 124 days median2018: 124 days median2019: 90 days median2020: 132 days median2021: 88 days median2022: 118 days median2023: 74 days median2024: 55 days median2025: 57 days median2026 (partial year): 96 days median
2007high 214 (2016) · low 55 (2024)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · MQV

1in 2025

2007: 52008: 32009: 12011: 62012: 32013: 22016: 12017: 12018: 22020: 12023: 32024: 22025: 12026 (partial year): 4
2007high 6 (2011) · low 0 (2010)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · MQV

57in 2025

2007: 672008: 712009: 812010: 682011: 1142012: 1492013: 2232014: 1112015: 1252016: 1062017: 1072018: 862019: 652020: 1262021: 1012022: 472023: 1202024: 682025: 57
2007high 223 (2013) · low 47 (2022)2025

MAUDE reports naming product code MQV, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200735144567
200832102371
200923180181
201017147068
201116926114
201291073149
2013121972223
2014201530111
2015181840125
201682141106
2017171241107
201823124286
20191390065
2020151321126
20218880101
20229118047
202321743120
20242855268
20251457157
20265964—

What is it indicated for?

GRAFTON®II eDBM is intended for use as a bone graft substitute, and bone void filler in bony voids or gaps of the skeletal system (i.e., spine, pelvis and extremities) not intrinsic to the stability of the bony structure. The voids or gaps may be surgically created defects or defects created by traumatic injury to the bone. GRAFTON®II eDBM is resorbed/remodeled and is replaced by host bone during the healing process.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K082615: Grafton R II Edbm, Demineralized Bone Matrix Allograft, Resorbable Calcium Salt Bone Void Filler Devices.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K082615

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026